HCPLive Editorial Staff

FlowMetric, Inc., discusses its VaxEffect, an immune monitoring platform and how it can be used to measure COVID-19 vaccine responses.

Those with a history of severe allergic reaction to vaccines are recommended to consider deferring on the recently approved COVID-19 vaccine.

Study data suggested that up to 80% of patients with Parkinson disease may have ophthalmologic symptoms.

The FDA has approved a quadrivalent formula of the adjuvanted seasonal influenza vaccine from Seqiris.